In this webinar, we will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the Pharmaceutical industry.
In this webinar we will discuss going beyond serialization and understanding why it’s not enough and the need to stay innovative and add value and protection to your current solutions. Register now.
Learn how companies use the cloud to optimize clinical trial designs and analyze real-world data and how cloud-based artificial intelligence and machine learning are clearing the patient enrollment bottleneck. Download this whitepaper.
How can patient-reported outcomes (PROs) advance healthcare and how can your organization put them to use? This webinar will review PRO reimbursement strategies and how to use PRO data in the post-approval environment. Register now!
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2) drug development and how to save time and money while maximizing the value of their drug development program. Register Now!
By shifting to a model that’s driven by market changes and HCP behavior instead of a regimented POA (plan of action) cycle, companies can provide the relevant and timely experiences that HCPs are looking for. Join this webinar to learn more.
Success in transferring a drug product process requires multi-variant thinking. This webinar will consider a product, wherever it is in its lifecycle, and how consistency, planning and communication form the building blocks for success in the manufacturing process transfer.
White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Download now.
A solid market intelligence plan is essential to keeping up with the latest healthcare innovations. But how can you find the most critical information when you’re drowning in data?
Discover how AI-powered tools are augmenting the way intelligence teams uncover relevant data in a fraction of the time. Download now!
Join as Diane Hayes, PHD, InCrowd President and Co-founder, reviews the results from the 2019 physician predictions survey and considers the year ahead. Register Now
A dependence on isolated, single-analyte biomarkers has resulted in disappointing results for patient selection & clinical trials. We’re using Health Expression Models combined with Predictive Immune Modeling to change the way we characterize disease. See results from our clinical validation study.
Discover key stats and valuable insights on how patient leaders and their peers in online communities share information. How likely are they to ask their doctor about specific medication? What platforms are used when information is shared privately? Get answers to these questions and more.
In the Quadruple Aim era, the pharma industry must shift its approach to Organized Customers and focus on providing B2B solutions.
To help you navigate this changing landscape, TKG executives and industry leaders have collaborated to bring you insights and ideas in this white paper. Download now!
Host cell proteins (HCPs) are common impurities in biologic drug products and are an obligatory critical quality attribute (CQA). The individual protein contaminants that make up the HCP profile, however, may vary significantly among individual biologic products and expression systems. As such, the HCP profile must be analyzed to identify even low levels of potentially concerning species in a biologic drug to ensure safety and efficacy. This whitepaper reviews fundamental aspects of HCPs pertaining to biologic drug development and current and emerging approaches to HCP analysis. Download Now.
Catalent’s biologics packaging operations in the US and Belgium offer state-of-the-art, high-speed, automated equipment, as well as configurable packaging solutions to support both clinical and commercial supply. Learn more about Catalent’s device assembly and packaging capabilities for biologics.
92% of survey respondents make changes to their RTSM/IRT systems due to study changes. See what else puts a strain on their clinical trials. Download the Research Whitepaper.
The challenges for new drugs looking to enter the market are numerous and varied, especially in small molecule development. Learn more about the most common API challenges to address in order to select a development partner with the ability to solve issues before they affect your timeline.
Catalent can formulate, fill, and package your product into vial, pre-filled syringe, or cartridge injectable formats that are ready-to-use for the patient or healthcare professional. Learn more about Catalent’s Biologics Drug Product capabilities and capacity at its US and Belgium sites.
Many patients take their medication inconsistently or incorrectly, addressing these challenges, unit dose solutions help increase patient adherence. Unit doses are a user-friendly and convenient solution that ensures patients receive an accurate dose every time, increasing safety and patient compliance. Download now.
In this poster, titled Developing a High-Throughput Formulation Development Platform for High-Concentration, Therapeutic Monoclonal Anitbodies, scientists at Catalent Biologics outline a method utilizing a high-throughput, micro-well plate platform to economically screen a mAb in 96 formulations. Download Here.
When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need, factoring in its estimate of the size of future sales, the timing of the launch, the dosage of the product, its strategy for building its market and a host of other variables. Download this whitepaper to learn how to strike the right balance between all of these factors.
How can we reduce our development timelines and costs—make things go faster, for less?
Answering those questions set Vertex on a path to challenge themselves and their vendors to improve speed without sacrificing quality. Attend this webinar to learn how Vertex is reducing database build times by as much as 50% and reliably lock data in 15-18 days.
This webinar will provide a PoV on R&D Operations from notable industry leaders with over 20+ years of experience designing, building and implementing R&D Operations capabilities within our industry. Register Now!
The advances in medical science over recent decades have been startling, yet the process of demonstrating the safety, efficacy, and patient value of new therapies and clinical practices remains inefficient. Download today.
This whitepaper explores how drug companies can take advantage of a variety of Lifecycle Management (LCM) strategies that prolong intellectual ownership of their innovative therapies while simultaneously allowing them to expand the ways their drug can address currently unmet patient needs. Download now.
As a scientist or researcher, you need fast, cost-effective access to scientific content. This guide covers useful tips and tools to accelerate your literature search, simplify access to papers, and minimize acquisition costs—putting you on the fast track to scientific discovery. Download Now.
In this white paper, we deep dive into the topic of launch excellence in challenging pharma markets. Download the report for exclusive case studies, tools and advice on how to:
- Develop an agile commercial model
- Ensure organisational alignment
- Apply commercial thinking earlier on
- Re-focus brand planning
- Engage customers with precision.
Each year, PwC's Health Research Institute (HRI) names the top issues for the health industry in the coming year. What made the list for 2019? Join HRI for a discussion of the most important trends for providers, insurers, pharma/life sciences and employers.
This survey examines the life sciences industry’s progress in reducing system and process complexity to improve study execution. This research aims to understand the drivers, benefits, and barriers of a unified clinical operating model.
Please take a moment to share your thoughts in this 15-minute survey.
This executive summary of a recent industry poll conducted by Seismic, the importance of sales enablement tools becomes clearer, as well as an apparent disconnect between understanding, implementation and measuring success of sales enablement programs within an organization. Learn more.
Join Joe Lipari, Director of Cloud Products at Systech, and special guest Peter Bryant, COO of FarmaTrust, as they explore the path to the future -- from compliance beyond the barcode to the blockchain-enabled pharmaceutical supply chain. Register now.
Join this webinar and explore how science and technology advances are providing unprecedented opportunity to change traditional ways of working in the life sciences industry from early drug develop through to commericalization. The healthcare landscape is changing; it’s never been more human. Maximize the value of digitization within your organization.
This webinar will explore both Right-to-Try legislation and existing Expanded Access Programs, including:
- Understanding sponsor responsibilities under these programs and when products may be eligible for these program
- Evaluating options such as treatment protocols, treatment INDs, and emergency use
- Discussing development risks associated with participation in these programs
In response to an increasing market demand, Cambrex has invested in a Continuous Flow Center enabling development of previously unfeasible process steps. Register for the Cambrex webinar on Continuous Flow Chemistry for APIs and Intermediates today.
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2), the pathway of choice. When executed properly, this regulatory pathway enables a lower cost, lower risk, and faster path to approval and market. Register Now!
Tying content to revenue and proving its ROI can be difficult. Join the webinar to learn why understanding content analytics is so important to medical device marketers, what metrics you should be tracking, and how sales enablement can help tie content to revenue. Register now!
Join Cardinal Health experts in the second of our three-part webinar series, as we review the qualitative phase of PRO instrument development within the context of an individual drug development program, PRO instrument modification and regulatory requirements associated with development of these measures for specific populations. Register now!
Modernizing manufacturing equipment, processes, and infrastructure with the newest technology has become a focus to improve their efficiency and overall bottom line. Attend this webinar and learn how to utilize connected IoT devices and data analytics to optimize manufacturing processes, novel ways to use machine learning technology in the cloud, and more.
Catalent’s new OptiGel® Mini technology can decrease capsule size by up to 30% to 50%, enabling delivery of a full strength dose in a smaller capsule. It allows better API absorption and easier swallowing that improves compliance, especially for pediatric and geriatric consumers. Click here to learn more.
Catalent can help you bring more OTC products to market faster and support your business objectives of driving brand growth and market share. Our vast product library can provide you 100+ proactively developed products for analgesic, digestive, sleep aids and cough, cold and allergy segments. Learn more now!
A global consumer healthcare company needed to revitalize one of their leading OTC brands. Softgel was the ideal solution to drive incremental growth. With a highly successful launch and halo growth for the entire brand, the new line extension increased the brand’s overall market share. Learn more here.
Join us to hear Steve Gens, managing partner at Gens and Associates, provide real-world examples for each step and guidance on how to justify making these changes within your organization. This webinar will outline five actionable steps to help you establish roles and responsibilities, institute key processes, and improve long-term outcomes. Register Now!
This webinar introduces a QSP model of targeted anabolic growth factors for intra-articular injection for the treatment of diseased joints that was used to systematically map out drug- and target-parameter space to:
- Identify tradeoffs between target and drug properties
- Maximize therapeutic window and tissue targeting
- Identify key missing data
Learn how to use advanced tools and technologies, such as natural language processing, to identify macro and micro healthcare market trends in the US, detect patterns in clinical trial protocol deviations, and discern patterns in patient sentiment, compliance, routines, behaviors, and overall treatment satisfaction and outcomes.
This webinar will examine the effect of technology advancements on the future responsibilities of clinical data managers and discusses the needs introduced by the application of new technologies and broader data source availability.
This webinar will discuss several capsule formulations used in DPIs and will compare their performance, an overview on some of the novel methods being employed to evaluate the physical characteristics and mechanical properties of capsules, and the factors influencing the aerosolisation performance of different capsule types. Register now!
Learn how unique patient segmentation and advanced analytics can be used to make serious gains in adherence rates with Ferring, Otsuka and Gideon Richter. Sign-up to the webinar now
We develop enabling formulations for pre-clinical drugs - parenteral, topical, and oral dosage forms. Our expertise includes nano-particles, nano-emulsions, amorphous dispersions, and controlled-release. We provide analytical development and GMP manufacturing for Phase I studies.
Come visit us at AAPS booth #2814
Clinical research and biobanking industries are rapidly adopting eConsent as an alternative to paper. Learn how eConsent can provide patients with clear and easy-to-understand clinical trial information, improve patient compliance, reduce inspection finding, and enable process efficiencies. Register now!
Download this FREE infographic for comparative data and valuable insider insights on newly approved drugs that pharma companies should consider for their products and marketing strategies.
Using a holistic approach to selecting and testing primary packaging and delivery systems can help pharmaceutical manufacturers mitigate particulate risk. Join West experts to learn how a holistic approach to drug product packaging, testing and evaluation can help reduce risk and overcome challenges associated with particulate. Register now!
It has been and big year for gene therapy. This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.
Download this FREE infographic for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
Every day, 2.5 quintillion bytes of data are created; 1/3 of that data is healthcare-related. Given the amount of information “noise” in the market, a new NPP landscape has emerged. HCPs now take initiative to source the information they need, when and where they want it (particularly in light of reduced rep access). Register Now!
With this report, discover what over 800 research professionals think about technology's impact on clinical trial operations and learn the necessary steps to see more value from your research systems. Click here to download.
Watch this webinar to hear from Bryan Knox on reliable approaches that have supported hundreds of small and virtual companies help build value to their lead candidates in early phases of development as well as help accelerate the development process to overcome formulation challenges. Register to watch on-demand.
Life sciences companies are embracing the essential roles that real world data (RWD) and the generation of real world evidence (RWE) play in the development of new treatments for patients.
This whitepaper will explore three areas where RWD and RWE are being applied to improve the design and execution of clinical studies. Download now to learn more.
Join this webinar to discover how ZipDose® by Aprecia enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. You’ll also review how 3DP can offer formulation advantages such as better molecule protection, adjustable powder layers and flexibility in dose loading for adaptive clinical trials.
Manufacturing is one of the most challenging environments in the pharmaceutical industry. This whitepaper discusses how new data acquisition and analytic technologies can boost manufacturing intelligence and agility, how companies like Merck and Moderna optimize manufacturing operations utilizing the cloud, and more. Download it now!